Source:http://linkedlifedata.com/resource/pubmed/id/19159616
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-2-6
|
pubmed:abstractText |
PSA (kallikrein hK3) proteolytic activity proved highly sensitive to reducing agents like dithiothreitol (DTT) and dihydrolipoic acid while beta-mercaptoethanol and glutathione were less effective. Ascorbate exhibited no significant inhibitory potential. Loss of activity by reduction could be readily reversed by re-oxidation. Inactivation was associated with the reduction of two out of five conserved disulfides. Mass spectrometry of differentially modified cysteines, and Edman degradation analyses identified Cys 22-Cys 157 and Cys 191-Cys 220 as DDT-sensitive. The highly homologous porcine pancreatic kallikrein (pK1) showed a completely different response: Even at 20 mM DDT, no inactivation was seen; and in this case, only one of the five disulfides (Cys 22-Cys 157) was opened. This indicated that it is the accessabilty of the Cys 191-Cys 220 disulfide near the catalytic serine 195 that decides on the ability of reductants to inactivate the proteolytic activity of PSA. A structural basis for this interpretation is provided when the two homologous proteins were compared with respect to the threedimensional architecture around the crucial disulfide Cys 191-Cys 220 where in the case of PK1, but not in PSA, the phenylalanine-residue (Phe 149) is in an interfering position.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cysteine,
http://linkedlifedata.com/resource/pubmed/chemical/Disulfides,
http://linkedlifedata.com/resource/pubmed/chemical/Dithiothreitol,
http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Kallikreins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1090-2104
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
20
|
pubmed:volume |
379
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1101-6
|
pubmed:meshHeading |
pubmed-meshheading:19159616-Amino Acid Sequence,
pubmed-meshheading:19159616-Cysteine,
pubmed-meshheading:19159616-Disulfides,
pubmed-meshheading:19159616-Dithiothreitol,
pubmed-meshheading:19159616-Humans,
pubmed-meshheading:19159616-Male,
pubmed-meshheading:19159616-Molecular Sequence Data,
pubmed-meshheading:19159616-Oxidation-Reduction,
pubmed-meshheading:19159616-Prostate-Specific Antigen,
pubmed-meshheading:19159616-Protein Conformation,
pubmed-meshheading:19159616-Tissue Kallikreins
|
pubmed:year |
2009
|
pubmed:articleTitle |
Prostate specific antigen: one out of five disulfide bridges determines inactivation by reduction.
|
pubmed:affiliation |
Institut für Biochemie und Molekularbiologie I, Universitätsklinikum Hamburg-Eppendorf, D-20246 Hamburg, Germany. weber@uke.uni-hamburg.de
|
pubmed:publicationType |
Journal Article
|